Search results
Bryhali dosage: Form, strength, how to use, and more
Medical News Today· 1 day agoBryhali (halobetasol) is a brand-name drug prescribed to treat plaque psoriasis in adults. Bryhali belongs to a drug class called corticosteroids. Note:...
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena via Yahoo Finance· 4 days agoLEO Pharma has announced positive data from the Phase III clinical trial of Enstilar (LEO 90100) in...
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 4 days agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 1 day agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 4 days agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
Rome Sentinel· 2 days agoAdalimumab-aaty is also available from Celltrion USA under the brand name YUFLYMA®, which launched in July 2023 and is available at a 5% discount to the current WAC list price of HUMIRA. Adalimumab-aaty ...
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 5 days agoIf the Phase Ia segment is successful, VYNE will advance the drug to Phase Ib trials in individuals...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 4 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 4 days agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 4 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...